Status:

COMPLETED

Effect of Continuous Positive Airway Pressure (CPAP) on Cognitive and Functional Performance in Stroke Patients With Obstructive Sleep Apnea

Lead Sponsor:

Toronto Rehabilitation Institute

Collaborating Sponsors:

The Physicians' Services Incorporated Foundation

Conditions:

Sleep Apnea, Obstructive

Cerebrovascular Accident

Eligibility:

All Genders

18-80 years

Phase:

PHASE3

Brief Summary

" Obstructive sleep apnea"(OSA) is a sleep breathing disorder. When a person with OSA tries to sleep the back of the throat closes and blocks the flow of air into lungs.When this happens, a person's s...

Detailed Description

Stroke occurs as a result of ischemic injury to neural tissue, as a result of cardiogenic or artery to artery embolism or intracranial arterial thrombosis. The traditional vascular risk factors, namel...

Eligibility Criteria

Inclusion

  • completed embolic, thrombo-embolic or hemorrhagic subacute strokes admitted within 3 weeks of stroke onset to the SRU of TRI.
  • all subjects must be able to follow simple commands in English based upon the Speech Language therapist's intake assessment and have competency to provide informed consent to participate in the study.

Exclusion

  • brainstem strokes due to increased aspiration risk with CPAP.
  • patients with previously diagnosed OSA or stroke.
  • diseases primarily or frequently affecting the central nervous system, including dementia, Parkinson's disease, multiple sclerosis,Huntington's disease or Lupus.
  • history of a psychotic disorder
  • stroke secondary to traumatic brain injury.

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2008

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00221065

Start Date

June 1 2005

End Date

October 1 2008

Last Update

February 5 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto Rehabilitation Institute

Toronto, Ontario, Canada, MG52A2